Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering

seekingalpha
2024-10-30
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) priced a public offering with a health-care focused institutional investor for the purchase and sale of up to ~2.95M shares and warrants to purchase up to ~2.95M shares at a combined offering price of $1.525 per share and accompanying warrant.
  • The aggregate gross proceeds of approximately $4.5M and assuming no exercise of the warrants. The warrants will have an exercise price of $1.40 per share.
  • The closing of the offering is expected to occur on or about October 31, 2024.
  • Net proceeds will be used to fund IND-enabling and Phase I and II clinical trials of product candidates, including $2.3M in payments that will be owed to Theradex Systems.
  • The stock price dropped 5.6% on Tuesday during after hours of trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10